About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT01266239

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

In study-1, the purpose of this study is to compare the long-term outcome of provisional stenting between EES and SES deployment. In study-2, it is to prove the following hypothesis " Asymmetrical exp...

Lead sponsor: Shin Yukuhashi Hospital•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Yoshinobu Murasato, MD, PhD

CONTACT

+81-930-24-8899 [email protected]

Yoshihisa Kinoshita, MD

CONTACT

+81-532-37-3377 [email protected]

Sponsors

Lead Sponsor

Shin Yukuhashi Hospital

Collaborators

Abbott Medical Devices
Cordis US Corp.

Kissing balloon inflation brings asymmetrical expansion which may lead to a risk of disturbance of endothelialization. We will investigate the following issues. 1. Impact of asymmetric expansion induced by kissing balloon technique on mid and long term results 2. Difference between SES and EES 3. Impact of abnormal OCT findings on long-term clinical outcome (3yr)

Age

20 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Coronary bifurcation lesion which stenotic lesion exists in the MV and / or in the side branch (SB).
•2. The lesion is appropriate for the provisional MV stenting.
•3. The reference diameter is more than 2.5mm in the MV and more than 2.0mm in the SB.

Exclusion Criteria

•1. Left main coronary bifurcation
•2. Acute myocardial infarction and unstable angina which culprit vessel contains obvious thrombus
•3. Left ventricular ejection fraction \< 30%
•4. Shock state
•5. Inappropriate candidate for the dual antiplatelet therapy, administration of contrast medium and radiation

Related studies

RECRUITINGPhase 2

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

NCT06145035 · Ischemic Heart Disease

Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)

NCT07569458 · Ischemic Heart Disease (IHD), Anxiety, and more

Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study

NCT05365282 · Ischemic Heart Disease, Nerve Injury, and more

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease

Sequent Extended Study

NCT05788432 · Coronary Artery Disease, Ischemic Heart Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 24, 2010Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment300

Start dateJul 2010

Last updatedDec 24, 2010

Condition

Ischemic Heart Disease

Locations shown

Kobe University

Kobe

Hyogo Medical University

Nishinomiya

Toyohashi Heart Center

Toyohashi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2010Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions